John Wilkin
Stock Analyst at Craig-Hallum
(2.47)
# 2,405
Out of 5,132 analysts
5
Total ratings
60%
Success rate
15.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $3.29 | +265.30% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $16.04 | -6.48% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $35.80 | +25.70% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $8.21 | -2.56% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $4.49 | +545.88% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $3.29
Upside: +265.30%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $16.04
Upside: -6.48%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $35.80
Upside: +25.70%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $8.21
Upside: -2.56%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $4.49
Upside: +545.88%